Upload
eden-baller
View
217
Download
0
Tags:
Embed Size (px)
Citation preview
Feb 25, 2013 (Epub ahead of print
Initial research teamG 03/140
RD 06/0045CIBERobn
www.predimed.es
Food industry: only food items
Provision of Olive oil~2 000 l/wk
Provision of nuts30 kg/wk walnuts15 kg/wk almonds
Men: 55-80 yr Women: 60-80 yr High CV risk without CVD
type 2 diabetics
3+ risk factors
PREDIMED TRIAL: DESIGN
Random
1. Smoking
2. Hypertension
3. LDL
4. HDL
5. Overweight/obes
6. Family history
Recruitment: primary care
N= 7,447
www.predimed.es
Random
Primary end-point: either –cardiovascular death
–myocardial infarction
–stroke
www.predimed.es
PREDIMED: interventionIntroduce changes in the overall food pattern
– Mediterranean diet: 2 groups• Total Fat: ad libitum• High in
– MUFA (virgin olive oil)– Fish – Fruits, vegetables, legumes
• Low in meats & dairy• alcohol permitted: wine
– Low-fat diet - Control• Reduce every fat• Increase CHO
– No Energy restriction– No specific recommendation on Physical Activity
tocopherols polyphenols flavonoids phytosterols
www.predimed.es
What is the Mediterranean diet?
1. Olive oil main culinary fat2. Olive oil >=4 tablespoons/d 3. Vegetables>=2 serv./d
4. Fruits>=3 serv./d5. Red meats<1/d
6. Butter, marg, cream<1/d7. Soda drinks<1/d
8. Wine >=7 glasses/wk9. Legumes >=3/wk10. Fish & seafood >=3/wk11. Cakes, sweets <3/wk12. Nuts >=3/wk13. Poultry > red meats14. Sofrito >=2/wk
14-itemscreener
Martínez-Gonzalez et al. Int J Epidemiol 2012;41:377
Sofrito
3
August 2012 Volume 7 Isue 8 e43134
Strategies for behavior change
Repeated personal contacts: every 3-mo Group sessions: every 3-mo Holistic approach• Written information• Self-monitoring• Individualized goal-setting• Quick feedback• Individual motivational interviews (every 3-mo)
– adapted to the patient’s features» clinical condition» preferences» beliefs
– expressed in servings/d to improve understanding
Additional strategies– Seasonal buying lists–Menus and recipes
Only in the 2 MeDiet groups• Provision of key food items
for free
Negotiated goal setting• Contracted agreement• Understandable: units=servings
Options for the negotiation• Serving size• Frequency of consumption• Way of cooking
3-yr attainments (%) for each of the 14 items
0
10
20
30
40
50
60
70
80
90
100
MeDiet + Virgin olive oil
MeDiet + mixed nutsControl group
-2
-1
0
1
2
3
4
5
6
7
Energy x 1000 Kcal
Prot (%E)
CHO (%E)
Fiber (g/d)
Fat (%E)
SFA (%E)
MUFA (%E)
PUFA (%E)
Nuts (%E)
Olive O. (%E)
FFQ: Changes in Energy, Nutrient and Supplemental Food Intake by Study Arm
p<.001 except fiber (p=0.10) & SFA (p=0.004) p<.001 except SFA (p=0.30)
MeDiet + Virgin olive oil
MeDiet + mixed nutsControl group
Urinary hydroxytyrosol concentrations (95% confidence intervals) at baseline and at 1, 3 and 5
years of follow-up (N = 750).
Plasma alpha-linolenic acid (%) in the three arms of the trial (95% confidence intervals) at baseline and at 1, 3 and 5 years of
follow-up (N = 375).
N Engl J Med 2013Suppl. Appendix
MeDiet+EVOO MeDiet+nuts Control0
2
4
6
8
10
12
8.1 8,0
11.2
Primary end-point (MI, stroke or death from CV causes)Crude rates / 1000 person-years N Engl J Med 2013
www.predimed.es
Unadjusted Adjusted (1) Addtionally-adj (2)
0.2
0.4
0.6
0.8
1
1.2
Haz
ard
Rat
ios
(95%
CI)
Unadjusted Adjusted (1) Additionally adj. (2)
0.2
0.4
0.6
0.8
1
1.2
Haz
ard
Rat
ios
(95%
CI)
Primary end-point
(1). Stratified according to recruiting center and adjusted for sex, age, family history of premature coronary heart disease, and smoking status.(2) Additionallly adjusted for body-mass index, waist-to-height ratio, hypertension at baseline, dyslipidemia at baseline, and diabetes at baseline.
N Engl J Med 2013
Primary end-point (MI, stroke or death from CV causes)
Stroke MI CV Death0.2
0.4
0.6
0.8
1
1.2
1.4
Haz
ard
Rat
ios
(95%
CI)
Stroke MI CV death0.2
0.4
0.6
0.8
1
1.2
1.4
Haz
ard
Rat
ios
(95%
CI)
Secondary end-points
Stratified according to recruiting center and adjusted for sex, age, family history of premature coronary heart disease, and smoking status, body-mass index, waist-to-height ratio, hypertension at baseline, dyslipidemia at baseline, and diabetes at baseline.
N Engl J Med 2013
Total mortality